12:00 AM
Jan 02, 2012
 |  BC Week In Review  |  Company News  |  Deals

Alopexx Enterprises LLC, Provenance deal

Alopexx and Provenance formed a JV to develop and commercialize Provenance's DI-Leu16-IL2. Provenance will contribute the compound and Alopexx will contribute $8 million...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >